trending Market Intelligence /marketintelligence/en/news-insights/trending/CsfsllQnD6XtaUKhFenbCw2 content esgSubNav
In This List

Oxford Immunotec starts offering for ordinary shares

Blog

How Financial Institutions are Managing Exposure to U.S. Municipals

Blog

Insight Weekly: Global stock performance; hydrogen pilot projects; Powell's Fed future unsure

Blog

Top 100 Banks: Capital Ratios Show Resilience to the Pandemic

Blog

Banking Essentials Newsletter: October Edition


Oxford Immunotec starts offering for ordinary shares

Oxford Immunotec Global PLC will sell 2.5 million ordinary shares in an underwritten public offering.

The company has granted the underwriter an option to buy up to 375,000 additional shares.

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

BTIG LLC is acting as sole underwriter for the offering.